Gritstone bio Stock

Gritstone bio ROE 2024

Gritstone bio ROE

-2.67

Ticker

GRTS

ISIN

US39868T1051

WKN

A2N4RX

In 2024, Gritstone bio's return on equity (ROE) was -2.67, a 281.15% increase from the -0.7 ROE in the previous year.

Gritstone bio Aktienanalyse

What does Gritstone bio do?

Gritstone Oncology Inc. is a biotechnology company based in California, USA, that develops innovative cancer immunotherapies. It was founded in 2015 by Dr. Andrew Allen and Dr. Alex Chaudhuri, and has been listed on the Nasdaq stock exchange with the ticker "GRTS" since 2018. The founders previously worked in the field of immunotherapy at Roche and Takeda and recognized the potential of personalized cancer therapies using immunology and cancer genomics technologies. With funding of over $220 million from investors such as Versant Ventures, The Column Group, and Frazier Healthcare Partners, the company has experienced strong growth in recent years. Gritstone Oncology follows an integrated business model that includes innovative platform technologies for identifying tumor antigens and developing personalized immunotherapies. The company uses advanced sequencing technologies and data analysis methods to detect individual cancer mutations and develop tailored therapies. Gritstone Oncology has two main product categories: cancer immunotherapies and cancer diagnostics. The company is developing various immunotherapies for the treatment of cancer, including a novel SARS-CoV-2/COVID-19 vaccine based on the same platform as their cancer immunotherapies. Additionally, Gritstone Oncology has developed a proprietary platform for the development of bispecific antibodies, which can simultaneously target two different objectives. They are also developing personalized immunotherapies that specifically target an individual patient's cancer mutations. The company also offers diagnostic tests to identify cancer mutations and determine therapeutic options. These include GPS Cancer, a genomic test that enables personalized cancer diagnosis and therapy, and SLATE, a diagnostic test that analyzes the immune status of tumor cells and surrounding tissues to develop personalized immunotherapy. In conclusion, Gritstone Oncology has become a leading company in the field of personalized cancer immunotherapy. It has strong growth potential due to its innovative technologies and research, as well as its highly experienced leadership and employees. The company will continue to play a critical role in cancer research and therapy and has the potential to improve the lives of millions of people worldwide. Gritstone bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Gritstone bio's Return on Equity (ROE)

Gritstone bio's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Gritstone bio's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Gritstone bio's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Gritstone bio’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Gritstone bio stock

What is the ROE (Return on Equity) of Gritstone bio this year?

The ROE of Gritstone bio this year is -2.67 undefined.

How has the Return on Equity (ROE) of Gritstone bio developed compared to the previous year?

The ROE of Gritstone bio has increased by 281.15% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Gritstone bio?

A high ROE indicates that Gritstone bio generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Gritstone bio?

A low ROE can indicate that Gritstone bio is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Gritstone bio affect the company?

A change in ROE (Return on Equity) of Gritstone bio can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Gritstone bio?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Gritstone bio?

Some factors that can influence Gritstone bio's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Gritstone bio pay?

Over the past 12 months, Gritstone bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Gritstone bio is expected to pay a dividend of 0 USD.

What is the dividend yield of Gritstone bio?

The current dividend yield of Gritstone bio is .

When does Gritstone bio pay dividends?

Gritstone bio pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Gritstone bio?

Gritstone bio paid dividends every year for the past 0 years.

What is the dividend of Gritstone bio?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Gritstone bio located?

Gritstone bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Gritstone bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Gritstone bio from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.

When did Gritstone bio pay the last dividend?

The last dividend was paid out on 11/17/2024.

What was the dividend of Gritstone bio in the year 2023?

In the year 2023, Gritstone bio distributed 0 USD as dividends.

In which currency does Gritstone bio pay out the dividend?

The dividends of Gritstone bio are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Gritstone bio

Our stock analysis for Gritstone bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gritstone bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.